home / stock / trib / trib quote
Last: | $3.05 |
---|---|
Change Percent: | -4.35% |
Open: | $2.88 |
Close: | $3.05 |
High: | $3.05 |
Low: | $2.785 |
Volume: | 12,887 |
Last Trade Date Time: | 07/30/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.05 | $2.88 | $3.05 | $3.05 | $2.785 | 12,887 | 07-30-2024 |
$2.76 | $2.85 | $2.76 | $2.9153 | $2.76 | 16,413 | 07-29-2024 |
$2.86 | $2.92 | $2.86 | $2.97 | $2.8006 | 12,640 | 07-26-2024 |
$2.99 | $3.12 | $2.99 | $3.15 | $2.9001 | 15,757 | 07-25-2024 |
$3.14 | $3.06 | $3.14 | $3.15 | $3.035 | 19,303 | 07-24-2024 |
$3.06 | $3.15 | $3.06 | $3.26 | $3.05 | 53,193 | 07-23-2024 |
$3.2 | $3.4 | $3.2 | $3.44 | $3.07 | 33,999 | 07-22-2024 |
$3.3 | $3.22 | $3.3 | $3.3 | $3 | 58,984 | 07-19-2024 |
$3.08 | $3.11 | $3.08 | $3.21 | $2.912 | 76,951 | 07-18-2024 |
$2.92 | $2.83 | $2.92 | $3.1999 | $2.76 | 41,557 | 07-17-2024 |
$2.82 | $3.15 | $2.82 | $3.38 | $2.76 | 133,117 | 07-16-2024 |
$3.06 | $3.33 | $3.06 | $3.3399 | $2.71 | 151,253 | 07-15-2024 |
$3.29 | $2.71 | $3.29 | $3.3 | $2.54 | 96,647 | 07-12-2024 |
$2.76 | $3.07 | $2.76 | $3.11 | $2.046 | 81,965 | 07-11-2024 |
$2.88 | $2.41 | $2.88 | $3.1 | $2.4 | 133,164 | 07-10-2024 |
$2.43 | $2.07 | $2.43 | $2.5 | $2.07 | 46,257 | 07-09-2024 |
$2.14 | $1.99 | $2.14 | $2.16 | $1.96 | 35,167 | 07-08-2024 |
$2.04 | $2.05 | $2.04 | $2.1769 | $2.04 | 16,604 | 07-05-2024 |
$2.14 | $2 | $2.14 | $2.2 | $2 | 19,224 | 07-04-2024 |
$2.14 | $2 | $2.14 | $2.2 | $2 | 19,224 | 07-03-2024 |
News, Short Squeeze, Breakout and More Instantly...
DUBLIN, July 09, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announces the appointment of Louise Tallon as Chief Financial Officer (“...
DUBLIN, June 24, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced steps to advance its next generation continuous glucose monitoring (...
DUBLIN, June 10, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, announces that its senior management team plans to at...